Recent News
Powered by Alpha Vantage
No recent news found.
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot
XOMA Corporation, a biotech royalty aggregator, discovers and develops therapeutic candidates in the United States, Europe, and Asia Pacific. The company is headquartered in Emeryville, California.
52W High
$27.20
52W Low
$23.32
MA Status:
50D: Below
200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.99
Valuation
Rich
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
26.73
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
N/A
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
N/A
Ownership
Retail‑heavySource: Overview
Insiders (1–5% typical)
0.00%
Institutions (25–75% balanced)
1.82%
Shares Outstanding
0
Float
9,356,900
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
2025-07-03
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
44,952,000
Gross Profit (TTM)
41,909,000
EPS (TTM)
1.00
Profit Margin (>10% good)
-0.22%
Operating Margin (TTM) (higher better)
0.35%
ROE (TTM) (>15% strong)
-0.10%
EPS YoY (Quarterly) (>10% good)
-0.48
Revenue YoY (Quarterly) (>8% good)
0.18
Momentum
Bearish momentumValue
0.2849
Previous
0.3469
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025